CMX 521
Alternative Names: CMX-521Latest Information Update: 28 Mar 2024
Price :
$50 *
At a glance
- Originator Chimerix
- Class Antivirals; Drug conjugates; Small molecules
- Mechanism of Action DNA-directed RNA polymerase modulators; Nucleoside reverse transcriptase inhibitors; Polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical COVID 2019 infections
- No development reported Norovirus infections
Most Recent Events
- 28 Mar 2024 No recent reports of development identified for phase-I development in Norovirus-infections in USA (PO)
- 28 Mar 2024 No recent reports of development identified for phase-I development in Norovirus-infections(Prevention) in USA (PO)
- 24 Feb 2022 CMX 521 is still in phase I trials for Norovirus-infections in USA